<HashMap><database>biostudies-literature</database><scores/><additional><submitter>He R</submitter><funding>NCI NIH HHS</funding><pagination>2064-6</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC3586706</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>49(20)</volume><pubmed_abstract>Mycobacterium protein tyrosine phosphatase B (mPTPB) is essential for the survival and persistence of Mycobacterium in the host. Thus small molecule inhibitors of mPTPB are potential anti-TB agents. We developed an efficient organocatalytic multicomponent reaction (MCR) between pyrrole, formaldehyde and aniline, affording a potent and selective mPTPB inhibitor with an IC(50) value of 1.5 μM and >50-fold specificity. Our studies provide a successful example of using organocatalysis as a discovery tool for the acquisition of PTP inhibitors.</pubmed_abstract><journal>Chemical communications (Cambridge, England)</journal><pubmed_title>Organocatalytic multicomponent reaction for the acquisition of a selective inhibitor of mPTPB, a virulence factor of tuberculosis.</pubmed_title><pmcid>PMC3586706</pmcid><funding_grant_id>R01 CA152194</funding_grant_id><funding_grant_id>CA152194</funding_grant_id><pubmed_authors>Zeng LF</pubmed_authors><pubmed_authors>Wu L</pubmed_authors><pubmed_authors>He Y</pubmed_authors><pubmed_authors>Gunawan AM</pubmed_authors><pubmed_authors>Zhang ZY</pubmed_authors><pubmed_authors>He R</pubmed_authors></additional><is_claimable>false</is_claimable><name>Organocatalytic multicomponent reaction for the acquisition of a selective inhibitor of mPTPB, a virulence factor of tuberculosis.</name><description>Mycobacterium protein tyrosine phosphatase B (mPTPB) is essential for the survival and persistence of Mycobacterium in the host. Thus small molecule inhibitors of mPTPB are potential anti-TB agents. We developed an efficient organocatalytic multicomponent reaction (MCR) between pyrrole, formaldehyde and aniline, affording a potent and selective mPTPB inhibitor with an IC(50) value of 1.5 μM and >50-fold specificity. Our studies provide a successful example of using organocatalysis as a discovery tool for the acquisition of PTP inhibitors.</description><dates><release>2013-01-01T00:00:00Z</release><publication>2013 Mar</publication><modification>2025-04-04T14:19:19.942Z</modification><creation>2019-03-27T01:05:30Z</creation></dates><accession>S-EPMC3586706</accession><cross_references><pubmed>23380872</pubmed><doi>10.1039/c3cc38961h</doi></cross_references></HashMap>